Skip to main content
Premium Trial:

Request an Annual Quote

Cepheid Moves Into New Digs

NEW YORK, May 15 - Cepheid today said today it has moved into its new headquarters in northern California.

 

The new facility, at 76,000 square feet twice the size of Cepheid's old digs, will allow the company to begin manufacturing its GeneXpert systems and test cartridges, the firm said. It is in Sunnyvale, Calif.

 

Click here for more information.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.